The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Open accessAbstract
Interactions between immune and malignant cells have been known to have clinical relevance for decades. The potential for immune control is now being therapeutically enhanced with checkpoint inhibitors and other novel agents to improve outcomes in cancer. The importance of the immune infiltrate as a prognostic marker is increasingly relevant. In this minireview, we present an overview of the immune infiltrate and its spatial organisation, and summarise the prognostic value of immune cells in different cancer types. International collaborative efforts are standardising histopathologic reporting of the immune infiltrate, to allow application of these parameters in the clinical and research settings. In general terms, a 'pro-inflammatory' tumour microenvironment and infiltrating CD8-expressing T lymphocytes are associated with improved clinical outcomes in a broad range of tumour types. The inhibitory function of other immune cells, for example, myeloid-derived suppressor cells and regulatory T cells, appear to have a major role in disrupting the capacity for the immune control of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F. L., Penault-Llorca, F., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu450 · Cited by 3,113
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Adams, S., Gray, R. J., Demaria, S., Goldstein, L., Perez, E. A., Shulman, L. N., Martino, S., Wang, M., Jones, V. E., Saphner, T. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0491 · Cited by 1,299
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Marvel, D., & Gabrilovich, D. I. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80005 · Cited by 1,050
Denkert, C., von Minckwitz, G., Brase, J. C., Sinn, B. V., Gade, S., Kronenwett, R., Pfitzner, B. M., Salat, C., Loi, S., Schmitt, W. D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.1967 · Cited by 1,026
Azimi, F., Scolyer, R. A., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S. W., Saw, R. P., & Thompson, J. F. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8539 · Cited by 856
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Hwang, W.-T., Adams, S. F., Tahirovic, E., Hagemann, I. S., & Coukos, G. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.09.039 · Cited by 661
Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay, N. E. H., Mosseri, V., Laccourreye, O., Bruneval, P., Fridman, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1886 · Cited by 598
Erdag, G., Schaefer, J. T., Smolkin, M. E., Deacon, D. H., Shea, S. M., Dengel, L. T., Patterson, J. W., & Slingluff, C. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3218 · Cited by 590
Ugel, S., De Sanctis, F., Mandruzzato, S., & Bronte, V. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80006 · Cited by 559
Sharma, P., Shen, Y., Wen, S., Yamada, S., Jungbluth, A. A., Gnjatic, S., Bajorin, D. F., Reuter, V. E., Herr, H., Old, L. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611618104 · Cited by 526
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
Ward, M. J., Thirdborough, S. M., Mellows, T., Riley, C., Harris, S., Suchak, K., Webb, A., Hampton, C., Patel, N. N., Randall, C. J., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.639 · Cited by 391
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Fridman, W. H., Galon, J., Pagès, F., Tartour, E., Sautès-Fridman, C., & Kroemer, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1316 · Cited by 380
Jochems, C., & Schlom, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011007 · Cited by 353
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
Nguyen, N., Bellile, E., Thomas, D., McHugh, J., Rozek, L., Virani, S., Peterson, L., Carey, T. E., Walline, H., Moyer, J., et al. (2016) · Head & Neck · doi:10.1002/hed.24406 · Cited by 353
Tumor infiltrating lymphocytes in ovarian cancer
Santoiemma, P. P., & Powell, D. J. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1040960 · Cited by 337
(2012) · Hepatogastroenterology · doi:10.5754/hge12420 · Cited by 332
Balermpas, P., Michel, Y., Wagenblast, J., Seitz, O., Weiss, C., Rödel, F., Rödel, C., & Fokas, E. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.640 · Cited by 309
Mei, Z., Liu, Y., Liu, C., Cui, A., Liang, Z., Wang, G., Peng, H., Cui, L., & Li, C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.46 · Cited by 305
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
Gabrielson, A., Wu, Y., Wang, H., Jiang, J., Kallakury, B., Gatalica, Z., Reddy, S., Kleiner, D., Fishbein, T., Johnson, L., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0110 · Cited by 299
Thomas, N. E., Busam, K. J., From, L., Kricker, A., Armstrong, B. K., Anton-Culver, H., Gruber, S. B., Gallagher, R. P., Zanetti, R., Rosso, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.3002 · Cited by 284
Mao, Y., Qu, Q., Chen, X., Huang, O., Wu, J., & Shen, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152500 · Cited by 275
He, G., Zhang, H., Zhou, J., Wang, B., Chen, Y., Kong, Y., Xie, X., Wang, X., Fei, R., Wei, L., et al. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0256-0 · Cited by 263
Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis
Geng, Y., Shao, Y., He, W., Hu, W., Xu, Y., Chen, J., Wu, C., & Jiang, J. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438523 · Cited by 253
Partlová, S., Bouček, J., Kloudová, K., Lukešová, E., Zábrodský, M., Grega, M., Fučíková, J., Truxová, I., Tachezy, R., Špíšek, R., et al. (2015) · OncoImmunology · doi:10.4161/21624011.2014.965570 · Cited by 241
Relevance of tumor-infiltrating lymphocytes in breast cancer
Dushyanthen, S., Beavis, P. A., Savas, P., Teo, Z. L., Zhou, C., Mansour, M., Darcy, P. K., & Loi, S. (2015) · BMC Medicine · doi:10.1186/s12916-015-0431-3 · Cited by 227
Balermpas, P., Rödel, F., Rödel, C., Krause, M., Linge, A., Lohaus, F., Baumann, M., Tinhofer, I., Budach, V., Gkika, E., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29683 · Cited by 199
Prognostic impact of B-cell density in cutaneous melanoma
Ladányi, A., Kiss, J., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejős, Z., Gaudi, I., Dobos, J., & Tímár, J. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1071-x · Cited by 199
Nordfors, C., Grün, N., Tertipis, N., Ährlund-Richter, A., Haeggblom, L., Sivars, L., Du, J., Nyberg, T., Marklund, L., Munck-Wikland, E., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.019 · Cited by 197
Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories
Man, Y.-G., Stojadinovic, A., Mason, J., Avital, I., Bilchik, A., Bruecher, B., Protic, M., Nissan, A., Izadjoo, M., Zhang, X., et al. (2013) · Journal of Cancer · doi:10.7150/jca.5482 · Cited by 192
Wolf, G. T., Chepeha, D. B., Bellile, E., Nguyen, A., Thomas, D., & McHugh, J. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2014.09.006 · Cited by 190
Pretscher, D., Distel, L. V., Grabenbauer, G. G., Wittlinger, M., Buettner, M., & Niedobitek, G. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-292 · Cited by 186
Immune signature of tumor infiltrating immune cells in renal cancer
Geissler, K., Fornara, P., Lautenschläger, C., Holzhausen, H.-J., Seliger, B., & Riemann, D. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.985082 · Cited by 175
Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma
Ladányi, A. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12371 · Cited by 168
Wang, B., Wu, S., Zeng, H., Liu, Z., Dong, W., He, W., Chen, X., Dong, X., Zheng, L., Lin, T., et al. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.02.2941 · Cited by 165
Bromwich, E. J., McArdle, P. A., Canna, K., McMillan, D. C., McNicol, A.-M., Brown, M., & Aitchison, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601400 · Cited by 162
Tu, J., Ding, Y., Ying, X., Wu, F., Zhou, X.-M., Zhang, D.-K., Zou, H., & Ji, J. (2016) · Scientific Reports · doi:10.1038/srep35056 · Cited by 156
Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancer
Wansom, D., Light, E., Thomas, D., Worden, F. P., Prince, M. E., Urba, S. G., Chepeha, D. B., Kumar, B., Cordell, K. G., Eisbruch, A., et al. (2011) · The Laryngoscope · doi:10.1002/lary.22133 · Cited by 153
Relapse or Eradication of Cancer Is Predicted by Peptide-Major Histocompatibility Complex Affinity
Engels, B., Engelhard, V. H., Sidney, J., Sette, A., Binder, D. C., Liu, R. B., Kranz, D. M., Meredith, S. C., Rowley, D. A., & Schreiber, H. W. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.018 · Cited by 149
Eckl, J., Büchner, A., Prinz, P. U., Riesenberg, R., Siegert, S. I., Kammerer, R., Nelson, P. J., & Noeßner, E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0806-7 · Cited by 142
Liotta, F., Gacci, M., Frosali, F., Querci, V., Vittori, G., Lapini, A., Santarlasci, V., Serni, S., Cosmi, L., Maggi, L., et al. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09555.x · Cited by 137
Sideras, K., Biermann, K., Verheij, J., Takkenberg, R. B., Mancham, S., Hansen, B. E., Schutz, H. M., de Man, R. A., Sprengers, D., Buschow, S. I., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1273309 · Cited by 134
Sjödahl, G., Lövgren, K., Lauss, M., Chebil, G., Patschan, O., Guðjónsson, S., Månsson, W., Fernö, M., Leandersson, K., Lindgren, D., et al. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.02.007 · Cited by 132
Harter, P. N., Bernatz, S., Scholz, A., Zeiner, P. S., Zinke, J., Kiyose, M., Blasel, S., Beschorner, R., Senft, C., Bender, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5696 · Cited by 132
Obeid, J. M., Erdag, G., Smolkin, M. E., Deacon, D. H., Patterson, J. W., Chen, L., Bullock, T. N. J., & Slingluff, C. L. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1235107 · Cited by 131
Kang, M. J., Kim, K. M., Bae, J. S., Park, H. S., Lee, H., Chung, M. J., Moon, W. S., Lee, D. G., & Jang, K. Y. (2013) · Translational Oncology · doi:10.1593/tlo.13256 · Cited by 124
Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome
Garg, K., Maurer‐Granofszky, M., Griss, J., Brüggen, M., Wolf, I. H., Wagner, C., Willi, N., Mertz, K. D., & Wagner, S. N. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.03.022 · Cited by 120
Punt, S., Dronkers, E. A. C., Welters, M. J. P., Goedemans, R., Koljenović, S., Bloemena, E., Snijders, P. J. F., Gorter, A., van der Burg, S. H., de Jong, R. J. B., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1805-x · Cited by 112
Brunner, S. M., Rubner, C., Kesselring, R., Martin, M. P., Griesshammer, E., Ruemmele, P., Stempfl, T., Teufel, A., Schlitt, H. J., & Fichtner‐Feigl, S. (2015) · Hepatology · doi:10.1002/hep.27728 · Cited by 105
Li, J., Chu, Y.-W., Wang, G. M., Zhu, T., Rong, R., Hou, J., & Xu, M. (2009) · BJU International · doi:10.1111/j.1464-410x.2008.08151.x · Cited by 102
Plasma cells in primary melanoma. Prognostic significance and possible role of IgA
Bosisio, F. M., Wilmott, J. S., Volders, N., Mercier, M., Wouters, J., Stas, M., Blokx, W. A. M., Massi, D., Thompson, J. F., Scolyer, R. A., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.28 · Cited by 94
Prognostic Significance of Tumor Infiltrating Lymphocytes in Melanoma
Burton, A. L., Roach, B. A., Mays, M. P., Chen, A. F., Ginter, B., Vierling, A. M., Scoggins, C. R., Martin, R. C. G., Stromberg, A. J., Hagendoorn, L. J., et al. (2011) · The American Surgeon · doi:10.1177/000313481107700219 · Cited by 92
Kakavand, H., Vilain, R. E., Wilmott, J. S., Burke, H., Yearley, J. H., Thompson, J. F., Hersey, P., Long, G. V., & Scolyer, R. A. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.110 · Cited by 91
Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis
Huang, Y. L., Liao, H., Zhang, Y., Yuan, R., Wang, F., Gao, Y., Wang, P., & Zhi, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094376 · Cited by 85
Mihm, M. C., & Mulé, J. J. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0143 · Cited by 83
Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma
Weiss, S. A., Han, S. W., Lui, K. P., Tchack, J., Shapiro, R. L., Berman, R. S., Zhong, J., Krogsgaard, M., Osman, I., & Darvishian, F. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.07.008 · Cited by 83
Sun, C., Xu, J., Song, J., Liu, C., Wang, J., Weng, C., Sun, H., Wei, H., Xiao, W., Sun, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5801 · Cited by 75
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Fortes, C., Mastroeni, S., Mannooranparampil, T. J., Passarelli, F., Zappalà, A., Annessi, G., Marino, C., Caggiati, A., Russo, N., & Michelozzi, P. (2015) · Melanoma Research · doi:10.1097/cmr.0000000000000164 · Cited by 73
Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis
Zhao, H., Li, W.-M., Lu, Z.-Q., & Yao, Y.-M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7971 · Cited by 65
PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma
Kogashiwa, Y., Yasuda, M., Sakurai, H., Nakahira, M., Sano, Y., Gonda, K., Ikeda, T., Inoue, H., Kuba, K., Oba, S., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11465 · Cited by 63
Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma
Knol, A., Nguyen, J., Quereux, G., Brocard, A., Khammari, A., & Dréno, B. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01260.x · Cited by 61
Eriksson, H., Frohm‐Nilsson, M., Järås, J., Kanter‐Lewensohn, L. R., Kjellman, P., Månsson‐Brahme, E., Vassilaki, I., & Hansson, J. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13171 · Cited by 55
Krpina, K., Babarović, E., & Jonjić, N. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1808-6 · Cited by 51
Saldanha, G. S., Flatman, K., Teo, K. W., & Bamford, M. W. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000848 · Cited by 50
Park, C. K., & Kim, S. K. (2017) · Oncotarget · doi:10.18632/oncotarget.14736 · Cited by 48
Stoll, G., Bindea, G., Mlecnik, B., Galon, J., Zitvogel, L., & Kroemer, G. (2015) · Oncotarget · doi:10.18632/oncotarget.4180 · Cited by 41
Sun, D., Zhao, M., Xia, M. X., Li, L., & Jiang, Y. (2011) · Medical Oncology · doi:10.1007/s12032-011-9903-2 · Cited by 38
Donizy, P., Kaczorowski, M., Hałoń, A., Leskiewicz, M., Kozyra, C., & Matkowski, R. (2015) · PubMed · Cited by 38
Prognostic role of tumour-infiltrating inflammatory cells in brain tumours
Bieńkowski, M., & Preusser, M. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000251 · Cited by 38
Zhang, Q., Hao, C., Cheng, G., Wang, L., Wang, X., Li, C., Qiu, J., & Ding, K. (2015) · PubMed · Cited by 30
Local Immune Response Predicts Survival in Patients with Thick (T4) Melanomas
Cintolo-Gonzalez, J., Gimotty, P. A., Blair, A., Guerry, D., Elder, D. E., Hammond, R., Elenitsas, R., Xu, X., Fraker, D. L., Schuchter, L. M., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3086-3 · Cited by 20
Caldeira, P. C., Sousa, A. D. A., & de Aguiar, M. C. F. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1541-x · Cited by 19
Hotta, K., Kato, Y., Leighl, N. B., Takigawa, N., Gaafar, R. M., Kayatani, H., Hirata, T., Ohashi, K., Kubo, T., Tabata, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121211 · Cited by 18
Wang, Q., Luan, W., Warren, L., Fiel, M. I., Blank, S., Kadri, H., Mandeli, J., & Hiotis, S. P. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000104 · Cited by 18
Infiltrating CD57+ Inflammatory Cells in Head and Neck Squamous Cell Carcinoma
Fraga, C. A. D. C., de Oliveira, M. V. M., Domingos, P. L. B., Botelho, A. C. D. C., Guimarães, A. L. S., Teixeira‐Carvalho, A., Corrêa‐Oliveira, R., & de Paula, A. M. B. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e318228357b · Cited by 16
Cited by
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Raskov, H., Orhan, A., Christensen, J. P., & Gögenur, I. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01048-4 · Cited by 1,687
CD8+ T cell states in human cancer: insights from single-cell analysis
van der Leun, A. M., Thommen, D. S., & Schumacher, T. N. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0235-4 · Cited by 1,472
Targeting Tumor Microenvironment for Cancer Therapy
Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187
Tumor-infiltrating lymphocytes in the immunotherapy era
Paijens, S. T., Vledder, A., de Bruyn, M., & Nijman, H. W. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00565-9 · Cited by 880
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Harjunpää, H., Llort Asens, M., Guenther, C., & Fagerholm, S. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01078 · Cited by 764
Metadata
- Authors
- Barnes, T. A., & Amir, E.
- Venue
- British Journal of Cancer
- Published
- 2017-07-13
- Volume
- 117
- Issue
- 4
- Pages
- 451-460
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2735904407
- Cited by
- 432
- References
- 82
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.